Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea's Antitrust Watchdog Says Rebates Continuing Despite New Law; Levies $11 Million In Fines

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's antitrust watchdog the Fair Trade Commission said rebates by both multinational and local Korean pharmaceutical companies are continuing even though doctors can be punished for accepting rebates under a new law that took effect late last year

You may also be interested in...



Korea FDA Targets 30 Firms For Offering Rebates; Orders 21 Drugs Off The Market For 30 Days

KFDA has imposed fines and ordered some drugs off the market for 30 days as penalties to pharma companies involved in rebates; more such actions are planned.

Korea Novel Drug Prices 50% Of Similar Countries, But A Window Opens For Reform

MNC pharma association in Korea lobbies for delinking generic drugs from new drug pricing in year ahead.

Korea Novel Drug Prices 50% Of Similar Countries, But A Window Opens For Reform

MNC pharma association in Korea lobbies for delinking generic drugs from new drug pricing in year ahead.

Related Content

UsernamePublicRestriction

Register

OM002409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel